Insight

Henry Rodriguez: Unraveling the mysteries of small cell lung cancer

Photo taken from Henry Rodriguez/LinkedIn

Feb 26, 2024, 11:16

Henry Rodriguez: Unraveling the mysteries of small cell lung cancer

Henry Rodriguez, Founding Director of the Office of Cancer Clinical Proteomics Research at the NCI, shared on LinkedIn:

“Exciting news in SCLC! A collaborative study by the National Cancer Institute (NCI), ICPC (International Cancer Proteogenome Consortium) China Team, and CPTAC (Clinical Proteomic Tumor Analysis Consortium) has published a comprehensive study, unraveling the mysteries of small cell lung cancer.

Their proteogenomic insights could pave the way for subtype-specific therapies. Kudos!”

View additional information.
Source: Henry Rodriguez/LinkedIn

cancer Cancer Moonshot Cancer research Clinical Proteomic Tumor Analysis Consortium CPTAC Henry Rodriguez ICPC International Cancer Proteogenome Consortium Lung cancer National Cancer Institute NCI OncoDaily Oncology proteogenomics SCLC small cell lung cancer

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage